Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial.
Ono M, Tomaniak M, Koenig W, Khamis R, de Silva R, Chichareon P, Kawashima H, Hara H, Gao C, Wang R, Huber K, Vrolix M, Jasionowicz P, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Windecker S, Onuma Y, Storey RF, Serruys PW. Ono M, et al. Among authors: piek jj. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):39-47. doi: 10.1093/ehjcvp/pvaa110. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 32956446 Clinical Trial.
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Mulder BJ, van der Doef RM, van der Wall EE, Tijssen JG, Piek JJ, van der Meer J, Dunning AJ. Mulder BJ, et al. Among authors: piek jj. Eur Heart J. 1994 Aug;15(8):1129-34. doi: 10.1093/oxfordjournals.eurheartj.a060639. Eur Heart J. 1994. PMID: 7988607 Clinical Trial.
Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe.
Piek JJ, Boersma E, di Mario C, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Peels HO, Serruys PW. Piek JJ, et al. Eur Heart J. 2000 Mar;21(6):466-74. doi: 10.1053/euhj.1999.1871. Eur Heart J. 2000. PMID: 10681487
Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions.
Appelman YE, Piek JJ, van der Wall EE, Redekop WK, van Royen EA, Fioretti PM, de Feyter PJ, Koolen JJ, Strikwerda S, Serruys PW, David GK, Tijssen JG, Lie KI. Appelman YE, et al. Among authors: piek jj. Int J Card Imaging. 2000 Aug;16(4):267-77. doi: 10.1023/a:1026576223669. Int J Card Imaging. 2000. PMID: 11219598 Clinical Trial.
Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty.
Albertal M, Regar E, Piek JJ, Van Langenhove G, Carlier SG, Thury A, Sianos G, Boersma E, de Bruyne B, di Mario C, Serruys PW; Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) Study Group. Albertal M, et al. Among authors: piek jj. Am Heart J. 2001 Jul;142(1):81-6. doi: 10.1067/mhj.2001.115590. Am Heart J. 2001. PMID: 11431661
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe.
Piek JJ, Boersma E, Voskuil M, di Mario C, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Peels HO, Serruys PW; DEBATE study group. Piek JJ, et al. Eur Heart J. 2001 Sep;22(18):1725-32. doi: 10.1053/euhj.2000.2587. Eur Heart J. 2001. PMID: 11511122 Clinical Trial.
684 results